Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Chi

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Cell Cycle (Georgetown, Tex.)|July 28, 2017
Identification of more potent imipridones, a new class of anti-cancer agentsAndrew S Chi
Neuro-Oncology|February 25, 2021
Radiogenomics identifying important biological pathways in gliomasRajan Jain, Andrew S Chi
Handbook of Clinical Neurology|January 11, 2012
Inhibiting angiogenesis in malignant gliomasAndrew S Chi, Patrick Y Wen
The Oncologist|September 24, 2013
Is there a role for bevacizumab in the treatment of glioblastoma?Andrew S Chi, Marc C Chamberlain
Science (New York, N.Y.)|January 10, 2009
Developmental biology. Pluripotent chromatin stateAndrew S Chi, Bradley E Bernstein
Expert Opinion on Therapeutic Targets|March 22, 2007
Inhibiting kinases in malignant gliomasAndrew S Chi, Patrick Y Wen
The Oncologist|August 11, 2016
In ReplyAmir T Fathi, Andrew S Chi
The New England Journal of Medicine|June 26, 2014
Case 8-2014: A man with headache, vomiting, and diplopiaTracey A Cho, Andrew S Chi, Pamela W Schaefer
Seminars in Roentgenology|February 7, 2018
State of the Art Treatment and Surveillance Imaging of GlioblastomasStefan Margiewicz, Christine Cordova, Andrew S Chi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Antiangiogenic strategies for treatment of malignant gliomasAndrew S Chi, Andrew D Norden, Patrick Y Wen
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Cell Cycle (Georgetown, Tex.)|July 28, 2017
Identification of more potent imipridones, a new class of anti-cancer agentsAndrew S Chi
Neuro-Oncology|February 25, 2021
Radiogenomics identifying important biological pathways in gliomasRajan Jain, Andrew S Chi
Handbook of Clinical Neurology|January 11, 2012
Inhibiting angiogenesis in malignant gliomasAndrew S Chi, Patrick Y Wen
The Oncologist|September 24, 2013
Is there a role for bevacizumab in the treatment of glioblastoma?Andrew S Chi, Marc C Chamberlain
Science (New York, N.Y.)|January 10, 2009
Developmental biology. Pluripotent chromatin stateAndrew S Chi, Bradley E Bernstein
Expert Opinion on Therapeutic Targets|March 22, 2007
Inhibiting kinases in malignant gliomasAndrew S Chi, Patrick Y Wen
The Oncologist|August 11, 2016
In ReplyAmir T Fathi, Andrew S Chi
The New England Journal of Medicine|June 26, 2014
Case 8-2014: A man with headache, vomiting, and diplopiaTracey A Cho, Andrew S Chi, Pamela W Schaefer
Seminars in Roentgenology|February 7, 2018
State of the Art Treatment and Surveillance Imaging of GlioblastomasStefan Margiewicz, Christine Cordova, Andrew S Chi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Antiangiogenic strategies for treatment of malignant gliomasAndrew S Chi, Andrew D Norden, Patrick Y Wen
Pageof 9